/** * WPForms Custom Honeypot * * @author Bill Erickson * @link http://www.billerickson.net/eliminate-spam-with-a-custom-honeypot/ * * @param string $honeypot, empty if not spam, honeypot text is used in WPForms Log * @param array $fields * @param array $entry * @param array $form_data */ function be_wpforms_custom_honeypot( $honeypot, $fields, $entry, $form_data ) { $honeypot_class = 'my-bio-field'; $honey_field = false; foreach( $form_data['fields'] as $form_field ) { if( false !== strpos( $form_field['css'], $honeypot_class ) ) { $honey_field = absint( $form_field['id'] ); } } if( !empty( $entry['fields'][$honey_field] ) ) { $honeypot = 'Custom honeypot'; } return $honeypot; } add_filter( 'wpforms_process_honeypot', 'be_wpforms_custom_honeypot', 10, 4 );
Select Page

What’s New

Closed Systems are the Future of Scalable Cell and Gene Therapy

Peter Walters of CRB discusses how to prepare for commercial success, including enclosure at the earliest stages of process development.

Read more (open access): https://bioprocessintl.com/manufacturing/facility-design-engineering/scalability-in-cell-and-gene-therapy-manufacture-how-todays-developers-are-preparing-for-tomorrows-commercial-success/

Goldilocks, Radiation, and Cataracts in Space

Richard B. Richardson details the role of oxygen in cataract development in US astronauts.

Read more:https://pubmed.ncbi.nlm.nih.gov/35917999/

B Cell Function, Development, and Metabolism are Regulated by HIF

A comprehensive review by Zhang et al. of immunoregulation by hypoxia and hypoxia-inducible factors.

Click here to read more (open access): https://www.frontiersin.org/articles/10.3389/fimmu.2022.967576/full

A Novel Photosynthetic Gel for Wound Healing

Developing novel treatments can require novel approaches, like that of Zhu et al., who mimicked peripheral artery disease in vitro to develop a novel topical gel to enhance localized hyperoxygenation.

Click here to read more (open access): https://www.nature.com/articles/s41598-022-14085-1

Hypoxia Improves MSC Therapeutic Potential

Silvestro et al. study congenital pulmonary airway malformations in infants and detail the role of hypoxia in therapeutic MSC applications.

Click here to read more (open access): https://pubmed.ncbi.nlm.nih.gov/35774062/

Mimicking the TME in Immunotherapy Studies

Ma et al. discuss drug resistance and epigenetic vulnerability in triple negative breast cancer.

Click here to read more: https://pubmed.ncbi.nlm.nih.gov/35840558/

Physioxia Diminishes Cellular Iron Dependency

New biosensors uncover altered cell metabolism in this study by Sevimli et al.

Click here to read more (open access): https://www.sciencedirect.com/science/article/pii/S221323172200091X

Simulating Pathological Hypoxia to Study Neurodegeneration

Thinard et al. discuss a novel approach to therapy at the blood brain barrier.

Click here to read more (open access): https://www.mdpi.com/1999-4923/14/7/1418

social media

Recent News

Phase Holographic Imaging (PHI) visits the Wake Forest Institute for Regenerative Medicine (WFIRM) to finalize an agreement concerning the automation of advanced quality control in large-scale biomanufacturing of regenerative therapies.


Testing Facility Called “Game Changer” in Regenerative Medicine. The RegeneratOR Test Bed is an exciting game changer. The testing facility, located in North Carolina, provides supportive technology at no cost allowing companies to test and prove their cell-based products at various stages of development.

recent publications

Labuz, D. F., et al. Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic stem cell therapy Journal of pediatric surgery. 2022; doi:10.1016/j.jpedsurg.2022.01.062

from the blog

Cytocentric Visionaries Hal Broxmeyer

Cytocentric Visionaries: Hal Broxmeyer November 27, 1944 ~ December 8, 2021 Hal Broxmeyer telling Randy Yerden about his latest findings in June 2016. The average height of the Cytocentric researcher has been reduced, now that we have lost a giant. Hal Broxmeyer...

Cytocentric Visionaries Randy Yerden p3

Cytocentric Visionaries: Randy Yerden, CEO BioSpherix Part Three: Seeing Cytocentric Principles in Action This post contains excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of BioSpherix, conducted with Randy Yerden, Founder and CEO of...

Top 5 Cytocentric Publications of 2017

Top 5 Cytocentric Publications of 2017   With the first approvals of CAR-T, 2017 was a big year for cell-based research and therapies. Some scientific publications stood out from the rest as far as Cytocentric™ advancement. These Cytocentric research publications...

GBSI Biopolicy Summit 2017

The GBSI BioPolicy Summit 2017 Changing Scientific Tools for Better Reproducibility   The 2017 BioPolicy summit from the Global Biological Standards Institute, hosted in San Francisco, was focused on digital tools, technologies and automation. It was an...

Cytocentric Visionaries Alan Blanchard p1

Cytocentric Visionaries: Alan Blanchard Cell Culture Automation for Reproducibility: People Never Do the Same Thing Twice   Alan Blanchard is the Chief Scientific Officer and Co-founder, along with Thomas Forest Farb, of Thrive Bioscience. They are...

Cytocentric Visionaries: David Lawrence

Cytocentric Visionaries: Dr. David Lawrence, University at Albany Inflammation and Oxidative Stress: Cell Conditions Matter, Even for CAR-T Dr. David A Lawrence is Professor and Chair of Environmental Health Sciences, at the School of Public Health and the...